These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle-A double-blind, placebo-controlled randomized trial. Lundin C; Danielsson KG; Bixo M; Moby L; Bengtsdotter H; Jawad I; Marions L; Brynhildsen J; Malmborg A; Lindh I; Sundström Poromaa I Psychoneuroendocrinology; 2017 Feb; 76():135-143. PubMed ID: 27923181 [TBL] [Abstract][Full Text] [Related]
31. Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects. Coelingh Bennink HJT; Zimmerman Y; Laan E; Termeer HMM; Appels N; Albert A; Fauser BCJM; Thijssen JHH; van Lunsen RHW Contraception; 2017 Nov; 96(5):322-329. PubMed ID: 27393080 [TBL] [Abstract][Full Text] [Related]
32. A double-blind trial of four medications to treat severe premenstrual syndrome. Diegoli MS; da Fonseca AM; Diegoli CA; Pinotti JA Int J Gynaecol Obstet; 1998 Jul; 62(1):63-7. PubMed ID: 9722128 [TBL] [Abstract][Full Text] [Related]
33. Hormonal therapy in the management of premenstrual syndrome. Tiemstra JD; Patel K J Am Board Fam Pract; 1998; 11(5):378-81. PubMed ID: 9796767 [TBL] [Abstract][Full Text] [Related]
34. YAZ in the treatment of premenstrual dysphoric disorder. Rapkin AJ J Reprod Med; 2008 Sep; 53(9 Suppl):729-41. PubMed ID: 18980045 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of the combined oral contraceptive ethinylestradiol/drospirenone (Yasmin) in healthy Chinese women: a randomized, open-label, controlled, multicentre trial. Guang-Sheng F; Mei-Lu B; Li-Nan C; Xiao-Ming C; Zi-Rong H; Zi-Yan H; Xiao-Ping J; Jian L; Shu-Ying W; Cheng-Liang X; Zheng-Ai X; Tian-Fu Y Clin Drug Investig; 2010; 30(6):387-96. PubMed ID: 20201608 [TBL] [Abstract][Full Text] [Related]
36. A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms. Brown C; Ling F; Wan J J Reprod Med; 2002 Jan; 47(1):14-22. PubMed ID: 11838304 [TBL] [Abstract][Full Text] [Related]
37. Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study. Larivée N; Suissa S; Eberg M; Joseph L; Eisenberg MJ; Abenhaim HA; Filion KB BJOG; 2017 Oct; 124(11):1672-1679. PubMed ID: 27704723 [TBL] [Abstract][Full Text] [Related]
38. Premenstrual dysphoric disorder symptom cluster improvement by cycle with the combined oral contraceptive ethinylestradiol 20 mcg plus drospirenone 3 mg administered in a 24/4 regimen. Marr J; Niknian M; Shulman LP; Lynen R Contraception; 2011 Jul; 84(1):81-6. PubMed ID: 21664515 [TBL] [Abstract][Full Text] [Related]